Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by Pocketsundialon Apr 11, 2018 7:10pm
61 Views
Post# 27870096

RE:RE:RE:RE:RE:Big Pharma

RE:RE:RE:RE:RE:Big PharmaAnd you have no problem with a century long coverup perpetrated by Big Pharma? it doesn't matter. Big multinational pharmaceutical companies wouldn't dare risk negative consumer sentiment. Id imagine they would need to aquire a company that acquired a cbd company or to much negative blowback
kittykarma wrote: You have a right to you opinion but in my humble opinion you couldn't be more wrong. Big pharma is going to be over CBDs like fleas on dogs and it's already started. Do you honestly believe that they are going to pass on such an opportunity? No way. The money in CBDs is going to rival the money made on opioids which are fast going out of style due to their addictive properties. The guy who was CEO for the company that put out OXYCONTIN is now involved in the marijuana industry...guess why? These people follow the money and for once, they will be able to claim pure intentions instead of being vilified. A win win for all.


Bullboard Posts